Avinash Rao Ullur, MD, FRCPC, DrNB, FASN, CHS

Another key message from the PISCES trial journey was the importance of persistence and creative funding for investigator-led research, especially without industry sponsorship. PISCES ultimately demonstrated a HR of 0.57 for primary cardiovascular outcomes. #CSN2026 @CSNSCN

Excellent discussion by Charmaine Lok on PISCES trial (on her birthday), evolved from the earlier FISH study. Despite positive findings of fish oil in cv outcomes, vascular access patency, FISH was viewed as a “negative”. @CSNSCN

Strong call for a national kidney disaster task force and dedicated clinical training pathways to improve emergency preparedness and coordinated responses for vulnerable kidney patients during disasters. @CSNSCN @ShaifaliSandal

Kidney care systems need proactive disaster preparedness rather than reactive responses. Discussions on identifying structural and perception gaps, empowering communities in crisis management, and building system-level resiliency for the kidney community. @ShaifaliSandal @CSNSCN

Important session by @ShaifaliSandal on disaster and emergency preparedness in kidney care. With increasing natural, human-caused, and infrastructure-related disasters globally, CKD patients face higher hospitalization risks & general population faces increased AKI risk. @CSNSCN

Great connecting with an inspiring group of community nephrologists at CSNAGM 2026. Grateful for the shared learning, collaboration, and dedication toward improving kidney care across Canada. #CSN2026 @CSNSCN

Lisa Miller and Danielle Moorman reviewed CKM mineral bone disease management. Vitamin D, phosphate restriction, and phosphate binders showed limited outcome benefits and may negatively impact quality of life. Strong emphasis on individualized management @CSNSCN

Metabolic acidosis treatment and protein restriction in CKM showed limited benefit on mortality or CKD progression, while potentially worsening side effects, malnutrition, and sarcopenia. Focus should remain on individualized nutrition and patient preferences. @CSNSCN

Excellent discussions on Conservative Kidney Management (CKM) by Sara Davison. A key message: CKM should be individualized, with goals centered around quality of life than strict biochemical normalization. Practice patterns vary significantly across Canada. #CSN2026 @CSNSCN

Vlado Perkovic - highlighting the evolving rx landscape aimed IgAN remission. Sibeprenlimab (APRIL inhibitor) & Atacicept (APRIL/BAFF inhibitor) - shown proteinuria reduction/remission results. Barrier is clinical inertia in timely diagnosis and rx escalation. @CSNSCN

In the current era of available therapies, no patient with diabetic kidney disease should routinely progress to dialysis without optimized evidence-based treatment. A practical 4-step remission-focused approach to CKD care may change long-term outcomes. @CSNSCN

Lunch symposium by Navdeep Tangri: powerful message: albuminuria is the gatekeeper of CKD progression, but CKD progression is no longer inevitable. With the right therapies, at the right time, in the right combinations, remission is increasingly achievable. #CSN2026 @CSNSCN

Super fantastic Canadian onco-neph group at #CSN2026 (although we are missing a few others in the pic☺️) @CSNSCN @onconeph

Prior abdominal surgery alone may not significantly affect outcomes unless adhesions are present. Lower eGFR at initiation appears associated with higher catheter-related complications and “rocky starts.” #CSN2026 @CSNSCN

Important procedural insights as well: ~10% of patients with PD catheters never achieve effective PD, and by 6 months nearly 25% experience catheter-related complications — flow issues being the most common. @CSNSCN

Excellent session by Matt Oliver on optimizing peritoneal dialysis (PD) utilization. A key message: focus on true eligibility and avoid empirical contraindications that may unnecessarily limit PD uptake. #CSN2026 @CSNSCN

AI still struggles with long complex histories and completeness of management — it needs to function as a partner in clinical care, not a replacement. @CSNSCN

Important perspective on where AI can realistically help nephrology: ambient documentation, clinic summaries, patient navigation, monitoring large follow-up populations for adverse events, integrating multimodal data for complex decisions, improving medication adherence @CSNSCN

Excellent talk by Dorry Segev on AI in healthcare. Artificial neural networks help train AI through pattern recognition — AI is not “thinking” independently. Generative AI/LLMs fundamentally work by predicting the next word or thought based on learned patterns. @CSNSCN #CSN2026